H.C. Wainwright Reiterates Buy on Abeona Therapeutics, Lowers Price Target to $11

H.C. Wainwright analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and lowers the price target from $15 to $11.

Benzinga · 12/30/2019 12:19

H.C. Wainwright analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and lowers the price target from $15 to $11.